CHM vs PER

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CHM

CHIMERIC FPO [CHM]

32LOW

PER

PERCHERON FPO [PER]

28LOW

Score Breakdown

CHM PER
Technical
58
53
Catalyst
55
50
Sentiment
50
50
Fundamental
6
0
Momentum
39
32
Risk Gate
27
30

Key Metrics

CHM Metric PER
$8.8MMarket Cap$6.7M
8.4MAvg Volume (20d)903K
N/AShort InterestN/A
$0.00952-Week High$0.013
$0.00152-Week Low$0.005
+0.0%Daily Change+0.0%
$0.002Entry Price$0.005
-1291.0%ROE-84.6%
-192.7%Profit MarginN/A

Active Signals

CHM Signals

●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (0.9x)
●Revenue in sharp decline (-53%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised downward (-10pts)

PER Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 9.1% over the last 5 days
●Critical cash runway (1.8 quarters)
●Low P/S ratio (3.9x)
●Revenue in sharp decline (-42%)

Ask Scout AI to compare CHM and PER in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CHM Full Analysis → PER Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).